Published in Blood Weekly, March 30th, 2000
The data indicate PCR screening may be valuable in identifying the presence of hepatitis B virus in plasma that has already cleared previous serology tests that screen for hepatitis B surface antigen, according to the company.
Investigational PCR screening, a form of nucleic acid testing (NAT), is designed to detect...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.